A. Ernest Toth Jr.
Chief Financial Officer, Aquestive Therapeutics, Inc.
Companies
- Aquestive Therapeutics, Inc.Chief financial officer Jan 8, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aquestive Therapeutics, Inc. AQST283,460 shares2$1.1M at $3.75May 5, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 5, 2026Shares withheld for tax 92,652 shares at $4.18 of Aquestive Therapeutics, Inc.2
- Mar 10, 2026Sold 58,254 shares at $4.17 of Aquestive Therapeutics, Inc.3
- Mar 9, 2026Granted 95,000 shares of Aquestive Therapeutics, Inc.3
- Mar 9, 2025Shares withheld for tax 8,736 shares at $2.65 of Aquestive Therapeutics, Inc.4
- Mar 7, 2025Shares withheld for tax 10,193 shares at $2.65 of Aquestive Therapeutics, Inc.4
- Mar 7, 2025Granted 110,000 shares of Aquestive Therapeutics, Inc.4
- Mar 9, 2024Shares withheld for tax 11,705 shares at $4.88 of Aquestive Therapeutics, Inc.5
- Mar 7, 2024Granted 120,000 shares of Aquestive Therapeutics, Inc.6
- Mar 9, 2023Granted 140,000 shares of Aquestive Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 11, 2026
- 4SEC EDGARForm 4 filed Mar 11, 2025
- 5SEC EDGARForm 4 filed Mar 12, 2024
- 6SEC EDGARForm 4 filed Mar 11, 2024
- 7SEC EDGARForm 4 filed Mar 9, 2023